World AIDS Day is observed every year on 1st December , serving as a global platform to raise awareness about HIV/AIDS, observe those who have passed away from the disease, and demonstrate support for those living with HIV. Established by the World Health Organization (WHO) in 1988, this day serves as a crucial reminder of the global health crisis caused by HIV/AIDS and the ongoing efforts to eliminate it, this event has been essential in educating people about the virus, supporting rights, and promoting prevention, treatment, and care.
World AIDS Day 2024 Overview | |
Aspect | Details |
Date | 1st December 2024 |
Theme | Take the Rights Path: My Health, My Right!” |
Observed Since | 1988 |
Organized By | WHO (World Health Organization) |
Purpose | Raise awareness about HIV/AIDS, support those living with HIV, and commemorate those who have died. |
Key Focus Areas | Awareness, prevention, treatment, and human rights advocacy. |
Global Statistics (2023) | 39.9 million living with HIV; 630,000 HIV-related deaths. |
Highest HIV Cases in India | Mizoram, Nagaland, and Manipur. |
Aspect | HIV (Human Immunodeficiency Virus) | AIDS (Acquired Immunodeficiency Syndrome) |
Definition | A virus that attacks the immune system, particularly CD4 cells (T cells). | A severe stage of HIV infection characterized by a weakened immune system. |
Cause | Caused by exposure to the HIV virus. | Caused by untreated or advanced HIV infection. |
Progression | It can remain in the body for years without significant symptoms if untreated. | Develops when HIV significantly damages the immune system. |
Symptoms | Flu-like symptoms in the early stages; can be asymptomatic for years. | Opportunistic infections, weight loss, and severe immune system damage. |
Diagnosis | Detected through blood or saliva tests for HIV antibodies or viral load. | Diagnosed when the CD4 count falls below 200 or with the presence of specific infections. |
Treatment | Managed with Antiretroviral Therapy (ART) to suppress the virus. | Requires ART and additional treatment for opportunistic infections. |
Curability | No cure, but manageable with treatment. | No cure; symptoms can be controlled with ART and supportive care. |
Purpose of Treatment | To prevent the progression of HIV to AIDS. | To manage infections and improve the quality of life. |
Prevention | Preventable through safe practices like using protection and avoiding needle sharing. | Prevention focuses on managing HIV effectively to avoid progression. |
Category | Key Statistics |
Global Prevalence | 39.9 million [36.1–44.6 million] people living with HIV in 2023. |
New Infections (2023) | 1.3 million [1–1.7 million] new cases globally. |
AIDS-Related Deaths (2023) | 630,000 [500,000–820,000] deaths reported worldwide. |
Antiretroviral Therapy (ART) | 30.7 million [27–31.9 million] accessing ART by the end of 2023. |
Cumulative Impact | 88.4 million infections since the epidemic began; 42.3 million AIDS-related deaths. |
People Living with HIV (2023) | Adults: 38.6 million; Children (0–14 years): 1.4 million. Women/Girls: 53% of the total. |
Treatment Access (2023) | 77% of all people with HIV, including 84% of pregnant women, had ART access. |
New Infections Decline | 60% reduction since 1995; new cases fell 39% between 2010 and 2023. |
AIDS Deaths Decline | Decreased by 69% since 2004 and 51% since 2010. |
High-Risk Groups | HIV prevalence is higher among: 7.7% of gay men, 5% of injecting drug users, and 9.2% of transgender people. |
Women and Girls Impact | Accounted for 44% of new infections globally and 62% in sub-Saharan Africa. |
Testing and Viral Suppression | 86% of people knew their status; 89% of them accessed ART, and 93% were virally suppressed. |
Funding (2023) | $19.8 billion available; a 5% decline from 2022. $29.3 billion is needed by 2025 to meet global targets. |
Indian Statistics Upon HIV and AIDS Cases |
|
Adults and children living with HIV | 2 500 000 [2 200 000 - 3 000 000] |
Adults aged 15 and over living with HIV | 2 500 000 [2 100 000 - 3 000 000] |
Women aged 15 and over living with HIV | 1 100 000 [960 000 - 1 300 000] |
Children aged 0 to 14 living with HIV | 61 000 [49 000 - 76 000] |
Adult aged 15 to 49 HIV prevalence rate | 0.2 [0.2 - 0.2] |
For women aged 15 to 49 HIV prevalence rate | 0.2 [0.2 - 0.2] |
Men aged 15 to 49 HIV prevalence rate | 0.2 [0.2 - 0.3] |
Adults and children newly infected with HIV | 68 000 [46 000 - 110 000] |
Adults aged 15 and over newly infected with HIV | 66 000 [44 000 - 100 000] |
Women aged 15 and over newly infected with HIV | 27 000 [18 000 - 42 000] |
Children aged 0 to 14 newly infected with HIV | 2300 [1300 - 4200] |
HIV incidence per 1000 population (all ages) | 0.05 [0.03 - 0.08] |
Adult and child deaths due to AIDS | 36 000 [24 000 - 54 000] |
Deaths due to AIDS among adults aged 15 and over | 35 000 [23 000 - 52 000] |
Deaths due to AIDS among women aged 15 and over | 11 000 [6400 - 19 000] |
Deaths due to AIDS among children aged 0 to 14 | 1100 [<1000 - 2200] |
Launched in 2016, Project Sunrise focused on combating the spread of HIV/AIDS in the eight Northeastern states of India. The initiative aimed to address the rising prevalence of HIV, particularly among intravenous drug users, by increasing awareness, improving access to treatment, and enhancing infrastructure for prevention and care. It targeted 20 districts in these states to curb the epidemic in a region with high HIV prevalence |
Ready to take the next step in your UPSC journey? Enroll in our comprehensive course today!
UPSC Related Articles | ||
UPSC Prelims Questions | NCERT for UPSC Exam 2025 | UPSC Mains Admit Card |
UPSC Mains Exam Pattern | UPSC Scholarship Test | UPSC Result |